If you could vote on Brexit now which option would you choose?

AstraZeneca's COVID-19 Vaccine Has No Efficacy Against South African Virus Strain, Study Shows

According to a Phase 1b-2 trial published in the New England Journal of Medicine, the two-dose COVID-19 vaccine developed by Oxford University / AstraZeneca Plc (NASDAQ: AZN) was ineffective against mild-to-moderate infections caused due to mutated virus strain in South Africa,

Yahoo News UK - March 17, 2021

View the full story here: https://uk.news.yahoo.com/astrazenecas-covid-19-vaccine-no-103036443.html